国产亚洲AV综合人人澡小说_国产精品免费午夜在线a_国产成人免费观看视频_国产精品国产午夜免费看福利_一区二区三区日韩_撕开丝袜直顶而入在线视频_波多结依无码观看_无遮挡一级毛片私人影院_欧美日韩在线视频专区_国产一级九九久久毛片精品
<li id="4waig"><pre id="4waig"></pre></li>
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2012.02.11
2012年度預(yù)計(jì)日常關(guān)聯(lián)交易公告
2012.02.11
股票期權(quán)激勵(lì)計(jì)劃（草案）修訂稿
2012.02.11
關(guān)于《深圳市海普瑞藥業(yè)股份有限公司股票期權(quán)激勵(lì)計(jì)劃(草案)修訂稿》之獨(dú)立財(cái)務(wù)顧問報(bào)告...
2012.02.11
關(guān)于調(diào)整募投項(xiàng)目投資進(jìn)度的公告
2012.02.11
第二屆監(jiān)事會(huì)第十次會(huì)議決議公告
2012.02.11
第二屆董事會(huì)第十一次會(huì)議決議公告
2012.02.11
股票期權(quán)激勵(lì)計(jì)劃（草案）修訂稿摘要
2012.02.11
獨(dú)立董事公開征集委托投票權(quán)報(bào)告書
2012.01.14
關(guān)于證監(jiān)會(huì)確認(rèn)股權(quán)激勵(lì)計(jì)劃（草案）無異議并備案的公告
2012.01.11
關(guān)于控股子公司完成增資工商變更登記的公告
第一頁
上一頁
136
137
138
139
140
下一頁
最后一頁
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
